207 related articles for article (PubMed ID: 26251470)
41. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
42. Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture.
Gunduz F; Aboulnasr FM; Chandra PK; Hazari S; Poat B; Baker DP; Balart LA; Dash S
Virol J; 2012 Aug; 9():143. PubMed ID: 22863531
[TBL] [Abstract][Full Text] [Related]
43. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
44. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
45. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Ho W
J Viral Hepat; 2013 Jun; 20(6):385-94. PubMed ID: 23647955
[TBL] [Abstract][Full Text] [Related]
46. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
[TBL] [Abstract][Full Text] [Related]
47. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
[TBL] [Abstract][Full Text] [Related]
48. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice.
Blindenbacher A; Duong FH; Hunziker L; Stutvoet ST; Wang X; Terracciano L; Moradpour D; Blum HE; Alonzi T; Tripodi M; La Monica N; Heim MH
Gastroenterology; 2003 May; 124(5):1465-75. PubMed ID: 12730885
[TBL] [Abstract][Full Text] [Related]
49. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
50. Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activation.
Wang H; Xin X; Wang M; Han L; Li J; Hao Y; Zheng C; Shen C
Arch Virol; 2018 Jun; 163(6):1429-1438. PubMed ID: 29417241
[TBL] [Abstract][Full Text] [Related]
51. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
[TBL] [Abstract][Full Text] [Related]
52. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
53. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
Liu JP; Ye L; Wang X; Li JL; Ho WZ
Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
[TBL] [Abstract][Full Text] [Related]
54. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
[TBL] [Abstract][Full Text] [Related]
55. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
56. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
[TBL] [Abstract][Full Text] [Related]
57. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
Schöbel A; Rösch K; Herker E
Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
[TBL] [Abstract][Full Text] [Related]
58. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
[TBL] [Abstract][Full Text] [Related]
59. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
[TBL] [Abstract][Full Text] [Related]
60. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
